930 related articles for article (PubMed ID: 18025337)
1. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
3. The UNOS OPTN waiting list: 1988 to 1994. United Network for Organ Sharing. Organ Procurement and Transplantation Network.
Guo TJ; Daily OP; Davies DB
Clin Transpl; 1994; ():69-86. PubMed ID: 7547588
[TBL] [Abstract][Full Text] [Related]
4. Overview of the MELD score and the UNOS adult liver allocation system.
Martin AP; Bartels M; Hauss J; Fangmann J
Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
[TBL] [Abstract][Full Text] [Related]
5. The UNOS OPTN waiting list: 1988-1995.
Harper AM; Baker AS
Clin Transpl; 1995; ():69-84. PubMed ID: 8794255
[TBL] [Abstract][Full Text] [Related]
6. Results of the first year of the new liver allocation plan.
Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
[TBL] [Abstract][Full Text] [Related]
7. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
Edwards EB; Breen TJ; Guo T; Ellison MD; Daily OP
Clin Transpl; 1992; ():61-75. PubMed ID: 1306723
[TBL] [Abstract][Full Text] [Related]
8. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy.
Freeman RB; Edwards EB
Liver Transpl; 2000 Sep; 6(5):543-52. PubMed ID: 10980052
[TBL] [Abstract][Full Text] [Related]
9. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
11. Application of a continuous disease severity score to the OPTN liver waiting list.
Edwards EB; Harper AM
Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for liver transplantation waiting list mortality.
Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
[TBL] [Abstract][Full Text] [Related]
13. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
Freeman RB; Rohrer RJ; Katz E; Lewis WD; Jenkins R; Cosimi AB; Delmonico F; Friedman A; Lorber M; O'Connor K; Bradley J
Liver Transpl; 2001 Mar; 7(3):173-8. PubMed ID: 11244156
[TBL] [Abstract][Full Text] [Related]
15. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation.
Foxton MR; Kendrick S; Sizer E; Muiesan P; Rela M; Wendon J; Heaton ND; O'Grady JG; Heneghan MA
Transpl Int; 2006 Dec; 19(12):988-94. PubMed ID: 17081228
[TBL] [Abstract][Full Text] [Related]
16. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
[TBL] [Abstract][Full Text] [Related]
17. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
18. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
[TBL] [Abstract][Full Text] [Related]
19. Liver transplant recipient selection: MELD vs. clinical judgment.
Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
